SCHEMBL1719256

SCHEMBL1719256

O=C(Nc1cc(Cl)ccc1O)c1nn2c(C(F)(F)F)cc(-c3cccs3)nc2c1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.58
MEN1 O00255 3/20 0.58
KDM4E B2RXH2 11/20 0.55
ALDH1A1 P00352 10/20 0.55
LMNA P02545 3/20 0.55
MAPT P10636 5/20 0.49
ESR1 P03372 1/20 0.49
POLB P06746 1/20 0.49
BLM P54132 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
GAA P10253 3/20 0.48
THRB P10828 1/20 0.47
HTT P42858 2/20 0.46
APOBEC3A P31941 1/20 0.46
KCNMA1 Q12791 1/20 0.46
HPGD P15428 4/20 0.46
GLA P06280 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
RXFP1 Q9HBX9 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1719814 0.92 KMT2A (0.59) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL1718390 0.92 KMT2A (0.60) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL1718515 0.92 KMT2A (0.57) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL1718674 0.90 KMT2A (0.59) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL1718721 0.88 KMT2A (0.56) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL1719180 0.88 KMT2A (0.62) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL1719056 0.87 KMT2A (0.61) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL1718528 0.87 KMT2A (0.63) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL1718662 0.86 KMT2A (0.60) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL1718772 0.86 MAPT (0.61) KDM4EALDH1A1MAPTNPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP claimed
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP disclosed